Cadrenal Therapeutics, Inc. · NASDAQ:CVKD
Pham Quang X sold 7,400 Cadrenal Therapeutics, Inc. shares (Form 4)
Traded Jun 29, 2026 · Filed Jul 1, 2026
On Jun 29, 2026, Pham Quang X (Director, Chairman and CEO, 10% owner) sold 7,400 Cadrenal Therapeutics, Inc. shares at US$3.03 for US$22,422 under a trading plan, leaving 98,589 shares. Filed Jul 1, 2026 (Form 4).
- Sold
- 7,400 shares
- Price
- US$3.03
- Value
- US$22,422
- Holding after
- 98,589 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chairman and CEO, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | Sale | 7,400 | US$3.03 | 98,589 | Direct |
Source
Related
- Cadrenal Therapeutics, Inc.
- Pham Quang X
- Cadrenal Therapeutics, Inc. shareholders
- Form 4 · Pham Quang X · Jun 26, 2026
- Form 4 · Pham Quang X · Jun 24, 2026
- Form 4 · Pham Quang X · Jun 18, 2026
- Form 4 · Pham Quang X · Jun 15, 2026
- Form 4 · Pham Quang X · Jun 10, 2026
- Schedule 13G · PNC Financial Services Group, Inc. · Aug 7, 2026
- Form 4 · Pham Quang X · Jun 5, 2026
- Form 4 · Pham Quang X · Jun 2, 2026
- Form 4 · Pham Quang X · May 29, 2026
- Form 4 · Pham Quang X · May 26, 2026